Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy
Authors:
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (6) , 1090-1106.e3
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- GRADE guidelines: 7. Rating the quality of evidence—inconsistencyJournal of Clinical Epidemiology, 2011
- Durability of Radiofrequency Ablation in Barrett's Esophagus With DysplasiaGastroenterology, 2011
- Detection of Intestinal Metaplasia After Successful Eradication of Barrett’s Esophagus with Radiofrequency AblationDigestive Diseases and Sciences, 2011
- The role of argon plasma coagulation in the management of Barrett's esophagus: a single-center experienceGastrointestinal Cancer: Targets and Therapy, 2011
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Barrett’s oesophagus: long‐term follow‐up after complete ablation with argon plasma coagulation and the factors that determine its recurrenceAlimentary Pharmacology & Therapeutics, 2007
- Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trialGastrointestinal Endoscopy, 2005
- Durability of new squamous epithelium after endoscopic reversal of Barrett’s esophagusGastrointestinal Endoscopy, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986